Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Biodegradable Medical Implants: Reshaping Future Medical Practice

Xia B., Liu Y., Xing Y., Shi Z., Pan X.

Narrative Review, published in Adv Sci (Weinh) (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Adv Sci (Weinh) (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40782070
PMCID
PMC12462970
DOI
10.1002/advs.202508014
Citations
4

Abstract (original English)

Biodegradable medical implants have fundamentally transformed the field of biomedical engineering by providing sustainable and biocompatible alternatives that obviate the need for secondary surgical removal and facilitate endogenous tissue regeneration. This comprehensive review systematically evaluates recent advancements in biodegradable implants utilized across a spectrum of medical applications, including internal medicine, surgical interventions, and medical devices. The developments discussed herein signify substantial progress in material synthesis, characterization, and processing techniques, effectively addressing critical challenges associated with the integration of biodegradable devices into medical implants. Although biodegradable medical implants promise advanced patient care, widespread clinical translation is hindered by inconsistent degradation rates mismatched with healing timelines, insufficient load-bearing strength, and potential inflammatory or toxic by-products. Additionally, most studies exhibit application-material imbalances, inadequate in vivo validation, and poorly controlled degradation behavior. Future efforts must clarify degradation mechanisms and treat materials as therapeutic agents. By synthesizing recent findings and highlighting critical gaps, this review provides valuable insights to guide innovation in biodegradable implant technologies, u

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsHumansBiocompatible MaterialsTissue EngineeringProstheses and ImplantsAbsorbable ImplantsBiomedical EngineeringRegenerative Medicine

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.